From: The preliminary comparative results between Covid-19 and non-Covid-19 patients in Western China
n (%) | Covid-19 (n = 15) | Non-Covid-19 (n = 93) | P value |
---|---|---|---|
Gender (M) | 9 (60) | 61 (65.59) | 0.67 |
Age (years) | 46.40 ± 18.21 | 34.43 ± 18.80 | 0.024 |
Weight (Kg) | 70.27 ± 10.67 | 60.54 ± 12.33 | 0.019 |
Adults | 15 (100) | 77 (82.80) | 0.18 |
Comorbidities | 0.10 | ||
Hypertension | 3 (20) | 6 (6.45) | |
Diabetes | 1 (6.67) | 4 (4.30) | |
Chronic kidney disease | 1 (6.67) | 1 (1.08) | |
Stroke | 1 (6.67) | 1 (1.08) | |
Ventilation | 1 (6.67) | 0 | |
Epilepsy | 0 | 2 (2.15) | |
Gallstones | 0 | 2 (2.15) | |
Coronary atherosclerotic disease | 0 | 2 (2.15) | |
Tuberculosis | 0 | 1 (1.08) | |
Ovarian cancer | 0 | 1 (1.08) | |
Neurological headache | 0 | 1 (1.08) | |
Polymyositis | 0 | 1 (1.08) | |
Bronchitis | 0 | 2 (2.15) |